Search Results
Found 1 results
510(k) Data Aggregation
(228 days)
Sydney IVF Blastocyst Cryopreservation Kit is intended for use in assisted reproduction technologies for cryopreservation of blastocysts.
Sydney IVF Blastocyst Thawing Kit is intended for use in assisted reproduction technologies for thawing of cryopreserved blastocysts.
The Sydney IVF Blastocyst Cryopreservation and Thawing Kits are intended for cryopreservation and thawing of human blastocysts. The Sydney IVF Blastocyst Cryopreservation and Thawing Kits provide users with the ability to cryopreserve supernumerary embryos created during the in vitro fertilization procedure and then to thaw them for use at a future point in time.
The Sydney IVF Blastocyst Cryopreservation Kit consists of three solutions containing increasing concentrations of cryoprotectant (both glycerol and sucrose are used). These buffers were designed to be used sequentially in order to remove water from embryos prior to cryopreservation. The removal of water prevents ice crystal formation inside the embryo thereby limiting damage and improving viability. It contains 12 mg/mL Human Serum Albumin (HSA) and 0.01mg/mL Gentamicin. Sydney IVF Blastocyst Cryopreservation Kit is designed for use with Sydney IVF Blastocyst Thawing Kit.
The Sydney IVF Blastocyst Thawing Kit consists of four solutions with decreasing concentrations of cryoprotectants (sucrose) which are used sequentially throughout the thawing process. It contains 12 mg/mL Human Serum Albumin (HSA) and 0.01mg/mL Gentamicin. It is designed for use with Sydney IVF Blastocyst Cryopreservation Kit.
Sydney IVF Blastocyst Cryopreservation and Thawing Kits are provided in glass vials with Fluorotec® coated rubber stoppers held in place with a tamper evident seal. Sydney IVF Blastocyst Cryopreservation Kit is packaged in a carton box containing 3 x 20mL solutions per kit. The Sydney IVF Blastocyst Thawing Kit is packaged in a carton box containing 4 x 20mL solutions per kit.
The provided text describes a Special 510(k) submission for the Sydney IVF Blastocyst Cryopreservation Kit and Sydney IVF Blastocyst Thawing Kit (K152717). This submission is for reproductive media, not an AI/ML medical device. Therefore, many of the requested categories pertaining to AI/ML device studies (e.g., sample size for test set, data provenance, ground truth experts, adjudication methods, MRMC studies, standalone performance) are not applicable to this document.
However, I can extract information related to the device's performance, stability, and comparison to its predicate.
Here's the information that can be extracted:
1. A table of acceptance criteria and the reported device performance
| Acceptance Criteria | Predicate Device (K030441) Specification | Proposed Device (K152717) Specification | Performance (K152717) |
|---|---|---|---|
| pH | 7.3 - 7.5 | 7.3 - 7.5 | The product specifications are the same as the predicate. |
| Osmolality | 285 - 295 mOsm/kg | 285 - 295 mOsm/kg | The product specifications are the same as the predicate. |
| Endotoxin | < 0.40 EU/mL | < 0.40 EU/mL | The product specifications are the same as the predicate. |
| Mouse Embryo Assay (MEA) | 1-cell MEA (96hrs) with ≥75% of control that develop to blastocyst | 2-cell MEA (72hrs) with ≥80% of control that develop to blastocyst | Pass (validated by stability studies) |
| Sterility | Not explicitly stated but implied as part of "product specifications" and "aseptic filtration" | Not explicitly stated but implied as part of "product specifications" and "aseptic filtration" | The product specifications are the same as the predicate. |
| Shelf-life | 8 weeks at 2-8°C | 20 weeks at 2-8°C | 20 weeks at 2-8°C (validated by stability studies) |
| Proline concentration | Not specified (tested during stability) | Not specified (tested during stability) | Tested during stability studies. |
| Ammonia concentration | Not specified (tested during stability) | Not specified (tested during stability) | Tested during stability studies. |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
This information is not provided in the document. The stability studies and MEA tests would have involved specific sample sizes, but these are not disclosed.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
This is not applicable as the device is reproductive media, not an AI/ML diagnostic tool requiring expert ground truth in the context of image interpretation or similar.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done
Not applicable.
7. The type of ground truth used (expert concensus, pathology, outcomes data, etc)
For the MEA, the "ground truth" is the observation of embryo development to blastocyst stage, compared to a control group. For the chemical and physical properties (pH, osmolality, endotoxin, sterility), the ground truth is established by standard laboratory testing and measurements.
8. The sample size for the training set
Not applicable; this is not an AI/ML device with a 'training set'.
9. How the ground truth for the training set was established
Not applicable.
Ask a specific question about this device
Page 1 of 1